https://www.selleckchem.com/products/sm-164.html
Acquired activated protein C resistance (APCr) has been identified in antiphospholipid syndrome (APS) and systemic lupus erythematosus (SLE). To assess agreement between the ST-Genesia and CAT analysers in identifying APCr prevalence in APS/SLE patients, using three thrombin generation (TG) methods. APCr was assessed with the ST-Genesia using STG-ThromboScreen and with the CAT using recombinant human activated protein C and Protac in 105 APS, 53 SLE patients and 36 thrombotic controls. Agreement was expressed in % and by Cohen's kappa co
Like
Comment
Share
